RxDoctor Payments Data

Grant Land, PA

Medical · Conyers, GANPI 1508816570

Payments from drug & device makers

$6,154in general payments, 2019–2025

Across 392 payments — averaging $15.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$721
  • Lilly USA, LLC$672
  • Novo Nordisk$549
  • Amgen$364
  • Corium, LLC$350
  • Boehringer Ingelheim$284
  • plus $3K from 40 others

What the payments were for

  • Food & beverage$6,154100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,154 in reported general payments places this provider in the 85th percentile of 950 medical providers in Georgia.

See all medical providers in Georgia

Medicare billing

Part B allowed, 2024
$6,818
Medicare patients
48
Services billed
189

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter66$67,110
JanuviaSitagliptin Phosphate45$50,501
OzempicSemaglutide31$33,617
VraylarCariprazine Hcl17$27,258
RybelsusSemaglutide20$25,651
EliquisApixaban23$24,534
JardianceEmpagliflozin22$14,202
Tresiba Flextouch U-200Insulin Degludec14$13,013
XareltoRivaroxaban14$12,286
EntrestoSacubitril/Valsartan11$10,374
Aimovig AutoinjectorErenumab-Aooe12$8,676
Albuterol Sulfate HfaAlbuterol Sulfate97$2,816
Epinephrine11$2,724
SymbicortBudesonide/Formoterol Fumarate11$2,511
Gabapentin100$1,415

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$249$67,11066 claims
Novo NordiskOzempic, Rybelsus$549$59,26951 claims
MerckJanuvia$92$50,50145 claims
AbbVieVraylar$721$27,25817 claims
PfizerEliquis$232$24,53423 claims
Boehringer IngelheimJardiance$284$14,20222 claims
Johnson & JohnsonXarelto$61$12,28614 claims
NovartisEntresto$198$10,37411 claims
Hikma Pharmaceuticals USAEpinephrine$139$2,72411 claims
AstraZenecaSymbicort$246$2,51111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 950 medical providers in Georgia.

Other medical in Conyers

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →